Literature DB >> 20517588

[Speech perception in noise with and without FM technology].

H Hanschmann1, S Wiehe, J Müller-Mazzotta, R Berger.   

Abstract

BACKGROUND: In the presence of a (central) auditory processing disorder [(C)APD] central hearing processes are disturbed, leading to impaired speech perception in noise. Poor acoustics in educational institutions exacerbates the problem. In children affected by (C)APD this can result in impaired development of language, reading and writing acquisition as well as other skills.
MATERIALS AND METHODS: A total of 66 children aged 6-11 years completed the Oldenburg sentence test in noise (OlSa) with and without an FM system. Children with normal OlSa test results formed the control group (group 1), while group 2a comprised children with an unremarkable re-test result and group 2b comprised children who produced abnormal results even in the re-test.
RESULTS: All children achieved improved speech intelligibility using the FM system. The greatest difference between results with and without FM system was seen in group 2b (9.53 dB S/N). Group 1 achieved an improvement of 8.86 dB S/N and group 2a 7.89 dB S/N.
CONCLUSIONS: Children with detected auditory selection problems benefit most from the use of an FM system for improved speech understanding. This should be borne in mind in the diagnosis and therapy of these children.

Entities:  

Mesh:

Year:  2010        PMID: 20517588     DOI: 10.1007/s00106-010-2086-x

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  7 in total

Review 1.  Report of the Consensus Conference on the Diagnosis of Auditory Processing Disorders in School-Aged Children.

Authors:  J Jerger; F Musiek
Journal:  J Am Acad Audiol       Date:  2000-10       Impact factor: 1.664

2.  Effects of frequency modulation (FM) transmitter microphone directivity on speech perception in noise.

Authors:  M Samantha Lewis; Carl C Crandell; Nicole V Kreisman
Journal:  Am J Audiol       Date:  2004-06       Impact factor: 1.493

3.  [Auditory processing disorders : Consensus statement by the German Society for Phoniatry and Paedaudiology].

Authors:  A Nickisch; M Gross; R Schönweiler; V Uttenweiler; A am Zehnhoff-Dinnesen; R Berger; H J Radü; M Ptok
Journal:  HNO       Date:  2007-01       Impact factor: 1.284

4.  Acoustic conditions for speech communication in classrooms.

Authors:  E Pekkarinen; V Viljanen
Journal:  Scand Audiol       Date:  1991

5.  [Comparison between the old and new evaluation mode in the dichotic discrimination test].

Authors:  R Berger; T Demirakca
Journal:  HNO       Date:  2000-05       Impact factor: 1.284

6.  [Münchner screening of auditory perception disorders (MAUS)].

Authors:  A Nickisch; C Heuckmann; T Burger; C Massinger
Journal:  Laryngorhinootologie       Date:  2006-04       Impact factor: 1.057

7.  [Problems and possible solutions in evaluation of dichotic discrimination tests for children].

Authors:  R Berger; S Macht; H Beimesche
Journal:  HNO       Date:  1998-08       Impact factor: 1.284

  7 in total
  3 in total

1.  [Auditory processing and perception disorders: proposed treatment and management: guidelines of the German Society for Phoniatry and Pedaudiology].

Authors:  R Schönweiler; A Nickisch; A am Zehnhoff-Dinnesen
Journal:  HNO       Date:  2012-04       Impact factor: 1.284

Review 2.  [Guideline: Auditory processing and perception disorders: Proposal for treatment and management of APD : S1 guideline of the German Society of Phoniatrics and Pediatric Audiology].

Authors:  R Schönweiler; C Kiese-Himmel; K Plotz; A Nickisch; A Am Zehnhoff-Dinnesen
Journal:  HNO       Date:  2020-08       Impact factor: 1.284

3.  Hearing impairment after subarachnoid hemorrhage.

Authors:  Nicci Campbell; Carl Verschuur; Sophie Mitchell; Orlaith McCaffrey; Lewis Deane; Hannah Taylor; Rory Smith; Lesley Foulkes; James Glazier; Angela Darekar; Mark E Haacke; Diederik Bulters; Ian Galea
Journal:  Ann Clin Transl Neurol       Date:  2019-01-08       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.